(Q50997674)

English

Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study.

scientific article published on 28 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

0 references

1 reference

based on heuristic

inferred from title

Takashi Ishikawa

4

object named as

Takashi Ishikawa

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

author name string

Tatsuo Kanda

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

Kazuhito Yajima

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

Shin-Ichi Kosugi

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

Yoichi Ajioka

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

Katsuyoshi Hatakeyama

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

publication date

28 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

15

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

235-244

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

https://scigraph.springernature.com/pub.10.1007/s10120-011-0100-y

0 references

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Salvage gastrectomy following a combination of biweekly paclitaxel and S-1 for stage IV gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Complete response of a highly advanced gastric carcinoma to preoperative chemoradiotherapy with S-1 and low-dose cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0100-Y

21 January 2018

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful downstaging by S-1-based chemotherapy followed by surgical resections for gastric carcinoma with extensive distant lymph node metastasis - report of two cases and a review of cases with surgical resection after downstaging by S-1-based ch

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Japanese classification of gastric carcinoma--2nd English edition--response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of weekly paclitaxel following fixed three cycles of S-1-based chemotherapy for advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22033890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-011-0100-Y

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22033890

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50997674&oldid=1411121259"